TAVR minimally invasive, shorter hospital stay and costs without compromising safety or efficacy

Original title: Comparison of Transfemoral TranscatheterAortic Valve Replacement Performedin the Catheterization Laboratory(Minimalist Approach) Versus HybridOperating Room (Standard Approach). Outcomes and CostAnalysis. Reference: VasilisBabaliaros et al. J Am CollCardiolIntv 2014;7:898–904.

This retrospective study of a center analyzed the results of percutaneous aortic valve replacement (TAVR) performed with a minimally invasive technique that included the closure of the femoral access by percutaneous closure device, local anesthesia with conscious sedation and transthoracic echocardiography control compared with the standard surgical technique using femoral access, general anesthesia with endotracheal intubation and transesophageal echocardiography control. 

142 patients who received elective percutaneous aortic valve replacement (minimally invasive n = 70; standard technique n = 72) were included in total. There were no differences in baseline comorbidities of the two groups (STS score 10.6 ± 4.3 vs. 11.4 ± 5.8; p = 0.35). 

All procedures with minimally invasive strategy were successful although, one patient required general anesthesia and tracheal intubation. The room time (150 ± 48 min versus 218 ± 56 min, P <0.001), the time required in intensive area (22 h versus 28 h, p <0.001), total length of hospital stay until discharge (3 days versus 5 days, p <0.001) and all costs, were significantly lower with minimally invasive strategy. The 30-day mortality was similar (0% versus 6%, p = 0.12) as well as stroke rate and transient ischemic attack (4.3% versus 1.4%, p = 0.35). Moderate or severe paravalvular leak (PVL) was also similar (3% versus 5.8%, p = 0.4). At a mean follow-up of 435 days no significant difference in survival between the two strategies (minimally invasive 83% standard versus standard 82%; p = 0.639) were observed. 

Conclusion 

Percutaneous aortic valve replacement can be performed in a minimally invasive manner with equivalent morbidity and mortality to the standard strategy. A shorter hospital stay and reduced use of resources decrease hospital costs. 

Editorial Comment 

It is important to mention that the first case with minimally invasive strategy performed by the authors of this work was after 300 cases with the standard strategy. While the trend in all centers going in this direction, there is a learning curve that must be overcome. 

SOLACI

More articles by this author

ACC 2025 | TAVI in Low-Risk Patients: 5-Year Outcomes of EVOLUTE LOW RISK

Transcatheter aortic valve implantation (TAVI) is a valid alternative to surgery in low-risk patients with severe aortic stenosis. However, one of its main limitations...

ACC 2025 | BHF PROTECT-TAVI: Are Cerebral Protection Systems Necessary in TAVI?

TAVI has seen a steady increase in use, though stroke continues to be one of its unwanted complications, mostly ischemic and, less frequently, hemorrhagic. The...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

Prospective Analysis of the Feasibility of the PASCAL System for Transcatheter Mitral Repair: OneForAll Registry

Courtesy of Dr. Juan Manuel Pérez. Mitral transcatheter edge-to-edge repair (M-TEER) is an effective option for patients with severe mitral regurgitation who are at high...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...

ACC 2025 | TAVI in Low-Risk Patients: 5-Year Outcomes of EVOLUTE LOW RISK

Transcatheter aortic valve implantation (TAVI) is a valid alternative to surgery in low-risk patients with severe aortic stenosis. However, one of its main limitations...